CJC-1295 with DAC
CJC-1295 with DAC
CJC-1295 with DAC 5mg laboratory research vial. The DAC designation matters when identifying CJC-1295. Compare sizes and lot-specific COAs. Not for human or animal consumption.
CAS 446262-90-4

Compound information
- Compound identity
- CJC-1295 with DAC
- CAS number
- 446262-90-4
- Molecular formula
- C165H269N47O46
- Molecular weight
- 3647.2 g/mol
Reference values describe the named chemical form. Consult the lot-specific report for the material supplied.
Vial sizes and availability
- 5mg · $84.15 USD · In stock · estimated dispatch up to 2 weeks · Select 5mg
Material identity and evidence limits
The DAC designation matters when identifying CJC-1295. Do not substitute documentation for a no-DAC listing or a blend.
CJC-1295 with DAC: what the human studies measured
DAC identifies the albumin-binding modification, not a purity grade. The 2006 Ionescu–Frohman study describes a long-acting CJC-1295 analog that binds to albumin. Its findings cannot be assigned to a no-DAC listing merely because both names contain CJC-1295.
Teichman and colleagues’ 2006 randomized, placebo-controlled studies in healthy adults lasted 28 and 49 days and measured GH, IGF-I and pharmacokinetics. The separate pulsatility study examined hormone secretion in healthy men. Hormone measurements are not demonstrated muscle gain, injury recovery or long-term safety, and neither selected study tested this catalog lot or a CJC/Ipamorelin blend.
- Teichman et al., 2006: randomized CJC-1295 studies in healthy adults
- Ionescu and Frohman, 2006: albumin-binding CJC-1295 and GH pulsatility
Compare identity and documentation: CJC-1295 no DAC · CJC-1295 + Ipamorelin blend · Ipamorelin alone
Certificates of analysis
Certificates of analysis · COA Library · Research purchaser requirements
Match the full compound identity, size and lot to the original report. Availability and purchaser eligibility must be confirmed before fulfillment.
Browse all compounds · Compound reference index · How to read a COA